Intralesional cidofovir in the treatment of cutaneous warts in a renal transplant patient.
Cutaneous warts are often recalcitrant to conventional therapy in immunocompromised patients. Cidofovir is a potent antiviral agent shown to have a broad spectrum of action against DNA virus, including human papillomavirus. To determine the efficacy of intralesional cidofovir in the treatment of florid warts in an immunocompromised renal transplant patient. The patient received seven injections of intralesional cidofovir at 4 week intervals in his numerous palmar warts. Based on our results, intralesional cidofovir is a promising therapeutic modality in the treatment of cutaneous warts in the renal transplant population.